ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I

Recruiting

Phase 1

ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS IISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I

Sponsor:

Immusoft of CA, Inc.

Code:

NCT05682144

Conditions

Mucopolysaccharidosis IH/S

Mucopolysaccharidosis IS

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Autologous Plasmablasts (B cells)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-29. This information was provided to ClinicalTrials.gov by Immusoft of CA, Inc. on 2025-03-25.